NCT00039585 2015-04-30Imatinib Mesylate in Treating Patients With Refractory or Relapsed Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer, or Ovarian Low Malignant Potential TumorNational Cancer Institute (NCI)Phase 2 Completed